| Primary |
| Contraception |
69.3% |
| Product Used For Unknown Indication |
11.5% |
| Drug Use For Unknown Indication |
3.4% |
| Menstruation Irregular |
3.2% |
| Menstrual Cycle Management |
2.0% |
| Menorrhagia |
1.6% |
| Dysmenorrhoea |
1.1% |
| Migraine |
1.1% |
| Anticoagulant Therapy |
1.0% |
| Menstrual Disorder |
0.8% |
| Ovarian Cyst |
0.8% |
| Endometriosis |
0.8% |
| Headache |
0.6% |
| Depression |
0.6% |
| Pulmonary Embolism |
0.4% |
| Premenstrual Syndrome |
0.4% |
| Pain |
0.4% |
| Anxiety |
0.3% |
| Asthma |
0.3% |
| Thrombosis |
0.3% |
|
| Pulmonary Embolism |
32.9% |
| Deep Vein Thrombosis |
10.9% |
| Inappropriate Schedule Of Drug Administration |
7.1% |
| Thrombosis |
6.1% |
| Unintended Pregnancy |
5.1% |
| Metrorrhagia |
4.5% |
| Vomiting |
4.3% |
| Weight Increased |
3.7% |
| Cerebrovascular Accident |
3.2% |
| Urinary Tract Infection |
3.1% |
| No Adverse Event |
3.0% |
| Device Expulsion |
2.8% |
| Product Quality Issue |
1.9% |
| Pregnancy With Contraceptive Device |
1.9% |
| Vaginal Haemorrhage |
1.9% |
| Incorrect Drug Administration Duration |
1.7% |
| Vaginal Discharge |
1.5% |
| Pulmonary Infarction |
1.5% |
| Weight Decreased |
1.5% |
| Menorrhagia |
1.4% |
|
| Secondary |
| Contraception |
45.9% |
| Product Used For Unknown Indication |
9.0% |
| Menstruation Irregular |
7.2% |
| Menstrual Cycle Management |
5.6% |
| Menorrhagia |
5.3% |
| Anticoagulant Therapy |
3.9% |
| Migraine |
3.5% |
| Dysmenorrhoea |
3.4% |
| Depression |
2.3% |
| Endometriosis |
2.2% |
| Ovarian Cyst |
2.0% |
| Acne |
1.3% |
| Polycystic Ovaries |
1.3% |
| Drug Use For Unknown Indication |
1.2% |
| Pain |
1.1% |
| Pleuritic Pain |
1.1% |
| Anxiety |
1.0% |
| Menstrual Disorder |
1.0% |
| Hypertension |
0.9% |
| Hormone Therapy |
0.8% |
|
| Pulmonary Embolism |
19.1% |
| Weight Increased |
9.1% |
| Maternal Exposure Before Pregnancy |
6.5% |
| Vaginal Haemorrhage |
6.5% |
| Unintended Pregnancy |
6.3% |
| Urinary Tract Infection |
5.8% |
| Metrorrhagia |
4.8% |
| Thrombosis |
4.5% |
| Nausea |
4.3% |
| Vomiting |
4.3% |
| Off Label Use |
4.0% |
| Deep Vein Thrombosis |
3.8% |
| Inappropriate Schedule Of Drug Administration |
3.8% |
| Upper-airway Cough Syndrome |
2.5% |
| Varicose Vein |
2.5% |
| White Blood Cell Count Increased |
2.5% |
| Wisdom Teeth Removal |
2.5% |
| Withdrawal Bleed |
2.5% |
| Anxiety |
2.3% |
| Hypercoagulation |
2.3% |
|
| Concomitant |
| Contraception |
26.7% |
| Product Used For Unknown Indication |
15.3% |
| Crohn's Disease |
8.2% |
| Acne |
7.1% |
| Drug Use For Unknown Indication |
5.9% |
| Depression |
3.9% |
| Multiple Sclerosis |
3.6% |
| Post Coital Contraception |
3.5% |
| Pain |
3.0% |
| Premenstrual Syndrome |
2.9% |
| Migraine |
2.8% |
| Anxiety |
2.5% |
| Rheumatoid Arthritis |
2.5% |
| Oral Contraception |
2.2% |
| Gastrooesophageal Reflux Disease |
2.0% |
| Headache |
2.0% |
| Supplementation Therapy |
1.6% |
| Psoriasis |
1.5% |
| Asthma |
1.4% |
| Bipolar Disorder |
1.4% |
|
| Pregnancy |
9.9% |
| Menstruation Irregular |
9.0% |
| Vomiting |
9.0% |
| Vaginal Haemorrhage |
7.3% |
| Pulmonary Embolism |
6.9% |
| Unintended Pregnancy |
6.0% |
| Nausea |
5.6% |
| Pain |
5.6% |
| Paraesthesia |
5.6% |
| Injection Site Pain |
5.2% |
| Cholecystitis Chronic |
3.9% |
| Diarrhoea |
3.4% |
| Rash |
3.4% |
| Tremor |
3.0% |
| Vision Blurred |
3.0% |
| Weight Increased |
3.0% |
| Cholelithiasis |
2.6% |
| Drug Ineffective |
2.6% |
| Injection Site Erythema |
2.6% |
| Somnolence |
2.6% |
|
| Interacting |
| Contraception |
37.5% |
| Epilepsy |
25.0% |
| Migraine |
12.5% |
| Product Used For Unknown Indication |
12.5% |
| Smoking Cessation Therapy |
12.5% |
|
| Drug Interaction |
60.0% |
| Pregnancy With Contraceptive Device |
40.0% |
|
